<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="initiate clinical trials. For example, novel anti-ZIKV activities of enoxacin," exact="amodiaquine" post="and niclosamide were discovered recently using human neural progenitor"/>
 <result pre="trials. For example, novel anti-ZIKV activities of enoxacin, amodiaquine and" exact="niclosamide" post="were discovered recently using human neural progenitor cells, human"/>
 <result pre="also known as T-705, was approved against FLUAV in Japan;" exact="cidofovir" post="is an injectable antiviral medication used as a treatment"/>
 <result pre="are undergoing surveillance studies (phase IV). Azithromycin, chloroquine, cyclosporine, ezetimibe," exact="mycophenolic acid," post="nitazoxanide and rapamycin progressed to phase IV studies without"/>
 <result pre="surveillance studies (phase IV). Azithromycin, chloroquine, cyclosporine, ezetimibe, mycophenolic acid," exact="nitazoxanide" post="and rapamycin progressed to phase IV studies without approvals"/>
 <result pre="other coronaviruses (Figure 5 ). For example, teicoplanin, oritavancin, dalbavancin," exact="monensin" post="and emetine could be repurposed for treatment of COVID-19."/>
 <result pre="emetine could be repurposed for treatment of COVID-19. Teicoplanin, ritavancin," exact="dalbavancin" post="and monensin are approved antibiotics, whereas emetine is an"/>
 <result pre="be repurposed for treatment of COVID-19. Teicoplanin, ritavancin, dalbavancin and" exact="monensin" post="are approved antibiotics, whereas emetine is an anti-protozoal drug."/>
 <result pre="corona- as well as some other viral infections . Moreover," exact="chloroquine" post="and remdesivir were shown to effectively inhibit SARS-CoV-2 infection"/>
 <result pre="addition, clinical investigations into the effectiveness of lopinavir, ritonavir, remdesivir," exact="hydroxychloroquine" post="and arbidol against COVID-19 have started recently (NCT04252664; NCT0425487;"/>
 <result pre="viral strains. For example, a cocktail of nitazoxanide, favipiravir, and" exact="niclosamide" post="could be developed for the treatment of viruses belonging"/>
 <result pre="the protection of patients from the secondary infections. For example," exact="azithromycin" post="could be used against FLUAV and Chlamydophila pneumoniae, Haemophilus"/>
 <result pre="some agents, such as doxycycline, artesunate, omeprazole, nitazoxanide, suramin, azithromycin," exact="minocycline" post="and chloroquine, could have novel antibacterial, antiprotozoal, antifungal or"/>
 <result pre="its cost (Table S1). For example, the concomitant actions of" exact="ezetimibe" post="and statins could be beneficial for treatment of both"/>
 <result pre="of antivirals: broad-spectrum inhibitorsCurr Opin Infect Dis28201559660226524332 DenisovaO.V.KakkolaL.FengL.StenmanJ.NagarajA.LampeJ.Obatoclax, saliphenylhalamide, and" exact="gemcitabine" post="inhibit influenza a virus infectionJ Biol Chem2872012353243533222910914 DiseaseG.B.D.InjuryI.PrevalenceC.Global, regional,"/>
 <result pre="One82013e78425 FerreiraA.C.ReisP.A.de FreitasC.S.SacramentoC.Q.Villas Boas HoelzL.BastosM.M.Beyond members of the flaviviridae family," exact="sofosbuvir" post="also inhibits chikungunya virus replicationAntimicrob Agents Chemother632019 FinkS.L.VojtechL.WagonerJ.SlivinskiN.S.J.JacksonK.J.WangR.The antiviral"/>
 <result pre="acidic endosomes with broad antiviral effectsPLoS Pathog82012e1002976 KaoJ.C.HuangFuW.C.TsaiT.T.HoM.R.JhanM.K.ShenT.J.The antiparasitic drug" exact="niclosamide" post="inhibits dengue virus infection by interfering with endosomal acidification"/>
 <result pre="of slow proliferating HepG2-NTCP cellsJ Hepatol71201928930031077792 KuivanenS.BespalovM.M.NandaniaJ.IanevskiA.VelagapudiV.De BrabanderJ.K.Obatoclax, saliphenylhalamide and" exact="gemcitabine" post="inhibit Zika virus infection in vitro and differentially affect"/>
 <result pre="Zika virusNat Commun92018209029844387 SacramentoC.Q.de MeloG.R.de FreitasC.S.RochaN.HoelzL.V.MirandaM.The clinically approved antiviral drug" exact="sofosbuvir" post="inhibits Zika virus replicationSci Rep720174092028098253 Sarzotti-KelsoeM.BailerR.T.TurkE.LinC.L.BilskaM.GreeneK.M.Optimization and validation of"/>
 <result pre="and tagging of every replicase proteinPLoS One112016e0151616 WangY.M.LuJ.W.LinC.C.ChinY.F.WuT.Y.LinL.I.Antiviral activities of" exact="niclosamide" post="and nitazoxanide against chikungunya virus entry and transmissionAntiviral Res1352016819027742486"/>
 <result pre="of every replicase proteinPLoS One112016e0151616 WangY.M.LuJ.W.LinC.C.ChinY.F.WuT.Y.LinL.I.Antiviral activities of niclosamide and" exact="nitazoxanide" post="against chikungunya virus entry and transmissionAntiviral Res1352016819027742486 WatanabeM.ButhJ.E.VishlaghiN.de la"/>
</results>
